US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
オーストラリア
ASX
Vita Life Sciences Limited (VLS) 銘柄情報

Vita Life Sciences Limited (VLS)

2.50

0.00

(0.00%)

終了 6月25日 3:00PM

Vita Life Sciences Limited (VLS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.50

( - )

買値

2.45

売値

2.50

出来高

0.00

0.00 日の範囲 0.00

2.15 52 週間の範囲 2.84

時価総額

前日終値

2.50

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 17,016

発行済株式数

54,381,784

配当利回り

0.14 (5.79%)

PER

13.62

1 株当たり利益 (EPS)

0.18

歳入

93.27M

純利益

10.44M

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products thro... Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

vitalifesciences.com

本社

Mascot, Australia

設立

2026

Vita Life Sciences Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker VLS. The last closing price for Vita Life Sciences was AUD2.50. Over the last year, Vita Life Sciences shares have traded in a share price range of AUD 2.15 to AUD 2.84.

Vita Life Sciences currently has 54,381,784 shares in issue. The market capitalisation of Vita Life Sciences is AUD135.95 million. Vita Life Sciences has a price to earnings ratio (PE ratio) of 13.62.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.07	2.88065843621	2.43	2.5	2.43	7245	2.48052831	DE
4	0.07	2.88065843621	2.43	2.56	2.38	9838	2.47052852	DE
12	-0.01	-0.398406374502	2.51	2.6	2.35	16366	2.49497326	DE
26	-0.04	-1.57480314961	2.54	2.84	2.27	15897	2.53221438	DE
52	0.27	12.1076233184	2.23	2.84	2.15	14832	2.46975303	DE
156	0.73	41.2429378531	1.77	2.84	1.42	14870	2.12010463	DE
260	1.415	130.414746544	1.085	2.84	1.04	17106	1.89566985	DE

VLS - Frequently Asked Questions (FAQ)

What is the current Vita Life Sciences Limited share price?

The current share price of Vita Life Sciences Limited is AUD 2.50

How many Vita Life Sciences Limited shares are in issue?

Vita Life Sciences Limited has 54,381,784 shares in issue

What is the market cap of Vita Life Sciences Limited?

The market capitalisation of Vita Life Sciences Limited is AUD 135.95M

What is the 1 year trading range for Vita Life Sciences Limited share price?

Vita Life Sciences Limited has traded in the range of AUD 2.15 to AUD 2.84 during the past year

What is the PE ratio of Vita Life Sciences Limited?

The price to earnings ratio of Vita Life Sciences Limited is 13.62

What is the cash to sales ratio of Vita Life Sciences Limited?

The cash to sales ratio of Vita Life Sciences Limited is 1.46

What is the registered address of Vita Life Sciences Limited?

The registered address for Vita Life Sciences Limited is 1-5 Chalmers Crescent, Mascot, New South Wales, 2020

What is the Vita Life Sciences Limited website address?

The website address for Vita Life Sciences Limited is vitalifesciences.com

Which industry sector does Vita Life Sciences Limited operate in?

Vita Life Sciences Limited operates in the Pharmaceuticals sector

Stinger2014

Stinger2014 2分前

To me it’s not the selling, it’s who is buying so much!! That’s lot of $ being spent. Always, GL to buyers

US Market News

US Market News 3分前

HIVE Signs Long-Term HPC Colocation LOI with Investment-Grade Swedish Client at Boden, Retrofit to Support Up to 10,000 GB300 GPUsJune 25, 2026 7:00 AM
Newsfile

CA Market News

CA Market News 3分前

Zodiac Gold Mobilizes Drill Rig to Advance Resource Growth at Arthington Within the 16km Monterra TrendJune 25, 2026 7:00 AM
NewsfileVa

CA Market News

CA Market News 4分前

Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of ShareholdersJune 25, 2026 7:27 AM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"June 25, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ:

Haluz

You are all over the place. I’ll leave it here.

Z06 MAN

Z06 MAN 4分前

Patience required while the company tries to bring the Holy Grail to market. So close…. It’s like Deja-Vu all over again… Tic-Toc 😂😂😂😂

valuemind

valuemind 6分前

Thank MU, SNDK up 15%!

SNDK may outperform MU during bull market and underperform during bear market.

Monksdream

Monksdream 6分前

SLOW, very slow

CryptoRain

CryptoRain 7分前

Or you’re entirely wrong and don’t know what you’re talking about

brazen22

brazen22 8分前

Not rejected is not the same as approved.

Do you think GBM patients waiting for access see 2.5 years without approval as beautiful?

speakhim

speakhim 8分前

Fact: "Ken has never been offered CEO position at BIEL. "
Anyone else care to ask the company ...?
Today is a new day. Let's move on , stop the games , do something meaningful,Read the Word, spend time with family , etc...

TheRealSarsoor

TheRealSarsoor 9分前

Good Morning $HGRAF

tedpeele

tedpeele 11分前

Tape-out seems to be one of the most misunderstood terms being used here.

Tape-out does not mean production immediately follows. It simply means the design has been released to the foundry.

More importantly, Lightwave has stated that it is in Stage 3. Any foundry cycle

t1215s

t1215s 11分前

OT:Good morning people, Boston it’s the ,”What’s good for the Goose should be good for the Gander thangggg
The dumDems(soon possibly to be the new socialist party) do it alllll the time to get what they want, Unfortunately we the people pay the price for whomever to get whatever passed , but

chilar4567

chilar4567 12分前

Paysign: A Real Turnaround Trade That Leaves Little Room For Growth
Inbox

SA Analysis Unsubscribe
Jun 24, 2026, 11:50?PM (6 hours ago)
to me

Paysign: A Real Turnaround Trade That Leaves Little Room For Growth

Trooperstocks

Trooperstocks 12分前

$BURU Nuburu said the Italian plan represents about $336.3 million in projected gross revenue from 2026 to 2029. The company projects $13.1 million in 2026 and $74.4 million in 2027. It also projects $105.7 million in 2028 and $143.1 million in 2029.

Trooperstocks

Trooperstocks 12分前

$BURU Nuburu said the Italian plan represents about $336.3 million in projected gross revenue from 2026 to 2029. The company projects $13.1 million in 2026 and $74.4 million in 2027. It also projects $105.7 million in 2028 and $143.1 million in 2029.

Haluz

Why after 2.5 years it has not been rejected? Quite unprecedented, isn’t it? Explain ! Beautiful things take time.

Denn55

Denn55 16分前

The Rat is working 24/7. Should get some news soon.

SCAMBUSTERKING

SCAMBUSTERKING 16分前

How long till no bid? 🤣

Monksdream

Monksdream 17分前

Nexera Technologies Ltd. operates as an e-commerce consumer products goods company. It operates as a holding company of three other e-commerce companies that operate online stores for the sale of various consumer products on the Amazon online marketplace, utilizing the Fulfillment by Amazon, or FBA

Truthsocial

Truthsocial 17分前

Current sentiment among investor communities suggests moderate to high odds of approval for this specific Early Feasibility pathway, citing several key factors:

Stronger Data Package: The submission includes extensive human clinical data from India and outcomes from over 100 IsoPet ve

CA Market News

CA Market News 18分前

Forward Water Technologies Corp. Announces Secured Bridge Debenture FinancingJune 25, 2026 7:00 AM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"June 25, 2026 /CNW/ - Forward Water Technologies Corp. ("FWTC"

US Market News

US Market News 18分前

Nuvation Bio Announces Proposed Convertible Senior Notes OfferingJune 25, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 25, 2026 /PRNewswire/ -- Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB)

US Market News

US Market News 18分前

Veeva Introduces New EHS Application for Proactive Risk Management and Intelligent AutomationJune 25, 2026 7:03 AM
PR Newswire (US) Environmental, health, and safety solution is part of Veeva Quality Cloud and will deliver real-time insig

Vita Life Sciences

Australian Critical Mine...

Al ML Innovations

Touchstone Dynamic Inter...

Van de Velde NV (PK)

Appia Rare Earths And Ur...

Australian Pharmaceutica...

Eaton Vance Enhanced Equ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。